Related Experiment Video

Updated: Jul 6, 2025

Microfluidics in Assessing Platelet Function
06:47

Microfluidics in Assessing Platelet Function

Published on: November 8, 2024

890

Molecular Insights into the Relationship Between Platelet Activation and Endothelial Dysfunction: Molecular

Niloufar Kazemi1, Armin Bordbar2, Samaneh Salehipour Bavarsad3

  • 1Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine, Iranian Blood Transfusion Organization (IBTO), Tehran, Iran.

Molecular Biotechnology
|January 6, 2024
PubMed

Insights

Platelet activation releases mediators that cause endothelial dysfunction, a key factor in cardiovascular disease. This study explores platelets

Area of Science:

  • Cardiovascular Biology
  • Hematology
  • Pathophysiology

Background:

  • Platelets are crucial coagulation cells involved in hemostasis.
  • Platelet activation releases mediators that impact endothelial cells (ECs).
  • Endothelial dysfunction (ED) is a significant factor in cardiovascular disease (CVD) pathogenesis.

Purpose of the Study:

  • To elucidate the role of platelet activation in endothelial dysfunction.
  • To investigate the prognostic implications of platelet activation in cardiovascular disease.
  • To explore the diagnostic and therapeutic potential of platelets in cardiovascular disease.

Main Methods:

  • Review of scientific literature on platelet function and endothelial cells.
  • Analysis of molecular pathways involved in platelet-mediated endothelial dysfunction.
  • Discussion of diagnostic markers and therapeutic targets related to platelet activation.

Main Results:

  • Platelet activation contributes to ED through inflammatory pathways, oxidative stress, and apoptosis.
  • Elevated markers like p-selectin indicate heightened platelet activation in CVD patients.
  • Platelet activation is linked to poorer prognosis in cardiovascular disease.

Conclusions:

  • Platelets play a critical role in the development and progression of endothelial dysfunction.
  • Platelet activation serves as a potential diagnostic marker and therapeutic target in cardiovascular disease.
  • Targeting molecular pathways of platelet activation may offer novel treatment strategies for CVD.

Keywords:
DiagnosticEndothelial DysfunctionMolecular PathwayPlateletPrognostic

More Related Videos

Real-time Imaging of Heterotypic Platelet-neutrophil Interactions on the Activated Endothelium During Vascular Inflammation and Thrombus Formation in Live Mice11:18

Real-time Imaging of Heterotypic Platelet-neutrophil Interactions on the Activated Endothelium During Vascular Inflammation and Thrombus Formation in Live Mice

Published on: April 2, 2013

15.7K
Preparation of Washed Human Platelets for Quantitative Metabolic Flux Studies07:06

Preparation of Washed Human Platelets for Quantitative Metabolic Flux Studies

Published on: January 10, 2025

524

Related Concept Videos

Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
6.3K
Structure and Function of Platelets01:18

Structure and Function of Platelets

The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
1.2K
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
2.7K
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
526
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
702